Inflation Reduction Act caps insulin costs, grants CMS drug negotiating power
Many of the health care changes in the Inflation Reduction Act, signed into law by President Biden on Aug. 16, will be rolled out over time, but the effect of the insulin cost ceiling and other aspects of the law are likely to have a more immediate impact on your patients.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.